-+ 0.00%
-+ 0.00%
-+ 0.00%

Boule Diagnostics, Q-Line Biotech Update Long-term India License Deal

MT Newswires·10/06/2026 08:59:48
Listen to the news
08:59 AM EDT, 10/06/2026 (MT Newswires) -- Boule Diagnostics (BOUL.ST) updated its long-term licensing agreement with Q-Line Biotech covering diagnostic reagents, consumables and hematology analyzers in India, according to a Tuesday release. The updated deal is designed to simplify the commercial structure, align incentives for long-term growth, and create a stronger base for expanding the diagnostics company's installed systems across the country as the use of RFID technology increases.